Considering Cryoport Inc. (CYRX) as a potential investment: What Should You Do?

The price of Cryoport Inc. (NASDAQ: CYRX) closed at $17.82 in the last session, down -5.86% from day before closing price of $18.93. In other words, the price has decreased by -$1.11 from its previous closing price. On the day, 505404 shares were traded. CYRX stock price reached its highest trading level at $19.11 during the session, while it also had its lowest trading level at $17.62.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



We take a closer look at CYRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.40 and its Current Ratio is at 15.00. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.75.

Upgrades & Downgrades

On November 05, 2021, ROTH Capital Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $78 to $90.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 16 when BERMAN RICHARD J sold 2,708 shares for $43.05 per share. The transaction valued at 116,588 led to the insider holds 107,203 shares of the business.

Hariri Robert J sold 2,000 shares of CYRX for $86,581 on Aug 11. The Director now owns 7,911 shares after completing the transaction at $43.29 per share. On Mar 09, another insider, Sawicki Mark W, who serves as the Chief Scientific Officer of the company, sold 1,410 shares for $31.05 each. As a result, the insider received 43,780 and left with 51,386 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.74 while its Price-to-Book (P/B) ratio in mrq is 1.60.

Stock Price History:

Over the past 52 weeks, CYRX has reached a high of $73.64, while it has fallen to a 52-week low of $15.79. The 50-Day Moving Average of the stock is 24.37, while the 200-Day Moving Average is calculated to be 29.85.

Shares Statistics:

According to the various share statistics, CYRX traded on average about 567.30K shares per day over the past 3-months and 639.7k shares per day over the past 10 days. A total of 48.52M shares are outstanding, with a floating share count of 48.08M. Insiders hold about 0.20% of the company’s shares, while institutions hold 95.70% stake in the company. Shares short for CYRX as of Oct 13, 2022 were 3.4M with a Short Ratio of 3.87M, compared to 2.83M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 7.01% and a Short% of Float of 7.20%.

Earnings Estimates

The company has 9 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.18, while EPS last year was -$0.18. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.04 and low estimates of -$0.17.

Analysts are recommending an EPS of between -$0.64 and -$0.89 for the fiscal current year, implying an average EPS of -$0.79. EPS for the following year is -$0.21, with 9 analysts recommending between $0.56 and -$0.6.

Revenue Estimates

According to 9 analysts, the current quarter’s revenue is expected to be $70.1M. It ranges from a high estimate of $71.72M to a low estimate of $67.44M. As of the current estimate, Cryoport Inc.’s year-ago sales were $56.69M, an estimated increase of 23.60% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $74.22M, an increase of 31.50% over than the figure of $23.60% in the same quarter last year. There is a high estimate of $75.95M for the next quarter, whereas the lowest estimate is $69.73M.

A total of 9 analysts have provided revenue estimates for CYRX’s current fiscal year. The highest revenue estimate was $263.4M, while the lowest revenue estimate was $253.63M, resulting in an average revenue estimate of $260.71M. In the same quarter a year ago, actual revenue was $222.61M, up 17.10% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $321.78M in the next fiscal year. The high estimate is $368.33M and the low estimate is $303.7M. The average revenue growth estimate for next year is up 23.40% from the average revenue estimate for this year.